Skip to main content
Equibles

Candriam S.C.A.

Position in ABT — Abbott Laboratories

CIK 1537014 STRASSEN, N4
Back to ABT Full portfolio

Position in ABT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$19,161,293
-$44,949,756 QoQ
Shares Held
211,167
-66.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#354
of 2,969 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $207,022,064 across 9 Medical Devices names. ABT ranks #5 (9.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EW
Edwards Lifesciences Corp
 663,784 $60,045,900
2 SYK
Stryker Corp
 161,744 $50,923,480
3 BRKR
Bruker Corp
 411,700 $24,776,106
4 PODD
Insulet Corp
 151,100 $23,004,975
5 ABT
Abbott Laboratories
This page 		211,167 $19,161,293
6 BSX
Boston Scientific Corp
 367,485 $15,684,259
7 DXCM
Dexcom Inc
 160,272 $10,794,319
8 GEHC
GE HealthCare Technologies Inc.
 21,571 $1,380,759

All Filings in ABT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,161,293 211,167
2026-03-31 $64,111,049 624,438
2025-12-31 $127,647,331 1,018,815
2025-09-30 $157,025,898 1,172,360
2025-06-30 $142,386,556 1,046,883
2025-03-31 $84,772,635 639,070
2024-12-31 $67,159,627 593,755
2024-09-30 $37,395,850 328,005
2024-06-30 $37,373,933 359,676
2024-03-31 $34,496,832 303,509
2023-12-31 $68,951,590 626,434
2023-09-30 $72,204,774 745,532
2023-06-30 $92,656,315 849,902
2023-03-31 $90,779,690 896,501
2022-12-31 $114,700,906 1,044,730
2022-09-30 $110,010,217 1,136,939
2022-06-30 $91,587,820 842,962
2022-03-31 $96,178,152 812,590
2021-12-31 $110,579,136 785,698
2021-09-30 $68,661,763 581,239
2021-06-30 $76,576,864 660,544
2021-03-31 $56,075,651 467,921
2020-12-31 $51,232,231 467,917
2020-09-30 $65,381,798 600,770
2020-06-30 $43,526,074 476,059
2020-03-31 $51,793,524 656,362